Found 5 matching trials
Study of NK012 in Patients With Refractory Solid Tumors
PHASE1The purpose of this study is to determine whether NK012 is safe and effecti...
Location
Sarah Cannon Research Institute
Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer
PHASE1The primary objective is to determine the maximum tolerated dose/recommende...
Location
Sarah Cannon Research Institute
Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
PHASE1The primary objective is to determine the maximum tolerated dose/recommende...
Location
Sarah Cannon Research Institute
A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
PHASE2The purpose of this study is to determine whether NK012 is safe and effecti...
Location
Sarah Cannon Research Institute
A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer
PHASE2The purpose of this study is to determine whether NK012 is safe and effecti...
Location
Sarah Cannon Research Institute